Molecular Insights into the Relationship Between Platelet Activation and Endothelial Dysfunction: Molecular Approaches and Clinical Practice.
Niloufar KazemiArmin BordbarSamaneh Salehipour BavarsadParisa GhasemiMaryam BakhshiZari Tahannejad AsadiPublished in: Molecular biotechnology (2024)
Platelets are one of the coagulation cells. When platelet activation occurs, many mediators are released and affect endothelial cells (ECs) and lead to endothelial dysfunction (ED). ED plays an important role in the pathogenesis of many diseases, including cardiovascular disease (CVD). Platelet are of important factors in ED. The release of mediators by platelets causes the stimulation of inflammatory pathways, oxidative stress, and apoptosis, which ultimately result in ED.On the other hand, platelet activation in CVD patients can be associated with a bad prognosis. Platelet activation can increase the level of markers such as p-selectin in the serum. Also, in this study, we have discussed the role of platelet as a diagnostic factor, as well as its use as a treatment option. In addition, we discussed some of the molecular pathways that are used to target platelet activation.
Keyphrases
- oxidative stress
- emergency department
- cardiovascular disease
- endothelial cells
- cell cycle arrest
- induced apoptosis
- end stage renal disease
- clinical practice
- type diabetes
- cell death
- dna damage
- newly diagnosed
- prognostic factors
- coronary artery disease
- peritoneal dialysis
- single molecule
- ischemia reperfusion injury
- combination therapy
- red blood cell
- heat shock